159 related articles for article (PubMed ID: 31486757)
1. Effect of the Histone Deacetylases Inhibitors on the Differentiation of Stem Cells in Bone Damage Repairing and Regeneration.
Zhao Q; Ji K; Wang T; Li G; Lu W; Ji J
Curr Stem Cell Res Ther; 2020; 15(1):24-31. PubMed ID: 31486757
[TBL] [Abstract][Full Text] [Related]
2. Harnessing the HDAC-histone deacetylase enzymes, inhibitors and how these can be utilised in tissue engineering.
Lawlor L; Yang XB
Int J Oral Sci; 2019 Jun; 11(2):20. PubMed ID: 31201303
[TBL] [Abstract][Full Text] [Related]
3. An epigenetic bioactive composite scaffold with well-aligned nanofibers for functional tendon tissue engineering.
Zhang C; Wang X; Zhang E; Yang L; Yuan H; Tu W; Zhang H; Yin Z; Shen W; Chen X; Zhang Y; Ouyang H
Acta Biomater; 2018 Jan; 66():141-156. PubMed ID: 28963019
[TBL] [Abstract][Full Text] [Related]
4. Inhibitors of histone deacetylases promote hematopoietic stem cell self-renewal.
Young JC; Wu S; Hansteen G; Du C; Sambucetti L; Remiszewski S; O'Farrell AM; Hill B; Lavau C; Murray LJ
Cytotherapy; 2004; 6(4):328-36. PubMed ID: 16146885
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of histone deacetylases by Trichostatin A leads to a HoxB4-independent increase of hematopoietic progenitor/stem cell frequencies as a result of selective survival.
Obier N; Uhlemann CF; Müller AM
Cytotherapy; 2010 Nov; 12(7):899-908. PubMed ID: 20210674
[TBL] [Abstract][Full Text] [Related]
6. [Biomaterials for bone defect repair and bone regeneration].
Jiang XQ
Zhonghua Kou Qiang Yi Xue Za Zhi; 2017 Oct; 52(10):600-604. PubMed ID: 29972932
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic Opportunities of Targeting Histone Deacetylase Isoforms to Eradicate Cancer Stem Cells.
Lin PC; Hsieh HY; Chu PC; Chen CS
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30004423
[TBL] [Abstract][Full Text] [Related]
8. Stem cells applications in bone and tooth repair and regeneration: New insights, tools, and hopes.
Abdel Meguid E; Ke Y; Ji J; El-Hashash AHK
J Cell Physiol; 2018 Mar; 233(3):1825-1835. PubMed ID: 28369866
[TBL] [Abstract][Full Text] [Related]
9. Histone deacetylase inhibitors as new cancer drugs.
Marks PA; Richon VM; Breslow R; Rifkind RA
Curr Opin Oncol; 2001 Nov; 13(6):477-83. PubMed ID: 11673688
[TBL] [Abstract][Full Text] [Related]
10. Protein acetylation in the cardiorenal axis: the promise of histone deacetylase inhibitors.
Bush EW; McKinsey TA
Circ Res; 2010 Feb; 106(2):272-84. PubMed ID: 20133912
[TBL] [Abstract][Full Text] [Related]
11. Effects of histone deacetylase inhibitors on regenerative cell responses in human dental pulp cells.
Luo Z; Wang Z; He X; Liu N; Liu B; Sun L; Wang J; Ma F; Duncan H; He W; Cooper P
Int Endod J; 2018 Jul; 51(7):767-778. PubMed ID: 28375564
[TBL] [Abstract][Full Text] [Related]
12. Histone deacetylases and their inhibitors: new implications for asthma and chronic respiratory conditions.
Royce SG; Karagiannis TC
Curr Opin Allergy Clin Immunol; 2014 Feb; 14(1):44-8. PubMed ID: 24322009
[TBL] [Abstract][Full Text] [Related]
13. Stem cell therapy in bone repair and regeneration.
Zaidi N; Nixon AJ
Ann N Y Acad Sci; 2007 Nov; 1117():62-72. PubMed ID: 18056038
[TBL] [Abstract][Full Text] [Related]
14. Induction of osteogenic differentiation of human mesenchymal stem cells by histone deacetylase inhibitors.
Cho HH; Park HT; Kim YJ; Bae YC; Suh KT; Jung JS
J Cell Biochem; 2005 Oct; 96(3):533-42. PubMed ID: 16088945
[TBL] [Abstract][Full Text] [Related]
15. [Histone modification and its application in therapy for hematologic malignancies -- review].
Fang MH; Ji XM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Jun; 17(3):816-20. PubMed ID: 19549415
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal cells for skeletal tissue engineering.
Slater BJ; Kwan MD; Gupta DM; Panetta NJ; Longaker MT
Expert Opin Biol Ther; 2008 Jul; 8(7):885-93. PubMed ID: 18549320
[TBL] [Abstract][Full Text] [Related]
17. Natural Product Inhibitors of Histone Deacetylases as New Anticancer Agents.
Hanikoglu A; Hanikoglu F; Ozben T
Curr Protein Pept Sci; 2018; 19(3):333-340. PubMed ID: 28059044
[TBL] [Abstract][Full Text] [Related]
18. Injectable degradable PVA microgels prepared by microfluidic technology for controlled osteogenic differentiation of mesenchymal stem cells.
Hou Y; Xie W; Achazi K; Cuellar-Camacho JL; Melzig MF; Chen W; Haag R
Acta Biomater; 2018 Sep; 77():28-37. PubMed ID: 29981495
[TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase inhibitors radiosensitize human melanoma cells by suppressing DNA repair activity.
Munshi A; Kurland JF; Nishikawa T; Tanaka T; Hobbs ML; Tucker SL; Ismail S; Stevens C; Meyn RE
Clin Cancer Res; 2005 Jul; 11(13):4912-22. PubMed ID: 16000590
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of histone acetylation as a tool in bone tissue engineering.
de Boer J; Licht R; Bongers M; van der Klundert T; Arends R; van Blitterswijk C
Tissue Eng; 2006 Oct; 12(10):2927-37. PubMed ID: 17518660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
